SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-21-000039
Filing Date
2021-11-30
Accepted
2021-11-30 16:07:44
Documents
12
Period of Report
2021-11-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20211130.htm   iXBRL 8-K 34949
  Complete submission text file 0001587221-21-000039.txt   170551

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20211130.xsd EX-101.SCH 1939
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20211130_lab.xml EX-101.LAB 23970
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20211130_pre.xml EX-101.PRE 12666
5 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20211130_htm.xml XML 10823
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 211459775
SIC: 2834 Pharmaceutical Preparations